Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > 3 nice upbeat articles within a week from Baystreet.....
View:
Post by Angler101 on Sep 26, 2023 5:30pm

3 nice upbeat articles within a week from Baystreet.....

Oncy is getting on the radar.......starting to attract a little more attention now.....
Comment by Buckhenry on Sep 26, 2023 10:05pm
I truly wished the pumpers were correct in their tarot card tricks 10% of the time... we would all be rich. 
Comment by canadafan on Sep 26, 2023 10:35pm
I look forward to seeing buckhenry drowning  in his shorts A $5 million gift & his is still producing a sea of nothingness. open statements with know substance. You are loosing all credibility. Today it was announced that the leading Pancreatic cancer organization in th3 USA PaCan, ...after much consideration & due diligence awarded $5 million to ONC to add another co- therapy ...more  
Comment by lonc17 on Sep 27, 2023 1:02am
$5 million grant is good news.  I hope PanCAN did their due dillegence and have a clause necessitating that Matt and Kirk et al will not use the money as a piggy bank to increase their already excessive compensation.
Comment by canadafan on Sep 27, 2023 5:18am
The $ is to be used to add an additional co- therapy alongside existing in the PanCan trial. that is why PanCan granted the $5million...not for day to day operations. read the N.R.
Comment by Lesalpes29 on Sep 27, 2023 7:06am
The Pancreatic Cancer Action Network (PanCAN) has awarded Oncolytics Biotech (TSX:ONC) a US$5 million grant to accelerate its research into treatments for pancreatic cancer The company will use the funds for ongoing clinical research on pelareorep, its investigational immunotherapy treatment, in combination with modified Folfirinox chemotherapy
Comment by Lesalpes29 on Sep 27, 2023 8:00am
I think Matt won't use the money to buy a bran new chalet! BOD are on a mission to give us and them many reasons to be happy! Stay the course. GLTAL 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities